Bosnia and Herzegovina vs Czechia: Proportion of bloodstream infection due to methicillin-resistant
Bosnia and Herzegovina
28.4%
in 2023
Czechia
28.5%
in 2023
Bosnia and Herzegovina rank
28th
Czechia rank
27th
Proportion of bloodstream infection due to methicillin-resistant over time
- Bosnia and Herzegovina
- Czechia
How they compare
Czechia currently reports 28.5% against 28.4% in Bosnia and Herzegovina, a difference of 0.1%.
The two have swapped places 3 times across 7 shared years of data; in 2017 it was Bosnia and Herzegovina ahead.
Bosnia and Herzegovina ranks 28th and Czechia ranks 27th of 55 countries.
Bosnia and Herzegovina has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bosnia and Herzegovina | Czechia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 17.6% | 13.1% | 4.4% | Bosnia and Herzegovina |
| 2020s | 24.8% | 13.7% | 11.0% | Bosnia and Herzegovina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of bloodstream infection due to methicillin-resistant, Bosnia and Herzegovina or Czechia?
- Czechia, at 28.5% against 28.4% in Bosnia and Herzegovina as of 2023.
- What is the difference in proportion of bloodstream infection due to methicillin-resistant between Bosnia and Herzegovina and Czechia?
- 0.1%, with Czechia ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and Czechia?
- 7 years are reported by both, from 2017 to 2023.
- How do Bosnia and Herzegovina and Czechia rank globally for proportion of bloodstream infection due to methicillin-resistant?
- Bosnia and Herzegovina ranks 28th and Czechia ranks 27th of 55 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.